Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (P) and standard platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) (AFT-09).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hensing, TA; Wang, XF; Gao, J; Stinchcombe, T; Knopp, MV; Dudek, AZ; Graziano, SL; Patel, JD; Faller, B; Dragnev, KH; Kozono, DE; Vokes, EE

Published Date

  • May 20, 2019

Published In

Volume / Issue

  • 37 / 15

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2019

Conference End Date

  • June 4, 2019